A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer.
about
Aberrant DNA methylation of OLIG1, a novel prognostic factor in non-small cell lung cancerUpdate in lung cancer 2007Confirmation of gene expression-based prediction of survival in non-small cell lung cancerHybrid models identified a 12-gene signature for lung cancer prognosis and chemoresponse predictionRETRACTED: A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunitiesNew molecularly targeted therapies for lung cancerInternational association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinomaIs there clinical value to prognostic signatures in early-stage NSCLC?A three gene-based risk score predicts prognosis of resected non-small-cell lung cancerCombining clinical, pathological, and demographic factors refines prognosis of lung cancer: a population-based studyA novel network model identified a 13-gene lung cancer prognostic signatureReinventing diagnostics for personalized therapy in oncologyGene expression-based classification of non-small cell lung carcinomas and survival predictionPre-clinical drug prioritization via prognosis-guided genetic interaction networksNuclear receptor expression defines a set of prognostic biomarkers for lung cancerUtilizing the molecular gateway: the path to personalized cancer management.Multigene expression-based predictors for sensitivity to Vorinostat and Velcade in non-small cell lung cancer.Data mining in genomicsEndoscopic ultrasound advances, part 1: diagnosis.Genomic markers for malignant progression in pulmonary adenocarcinoma with bronchioloalveolar featuresPrognostic gene signatures for non-small-cell lung cancer.Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer.Prediction of postoperative recurrence-free survival in non-small cell lung cancer by using an internationally validated gene expression modelBRCA1: a novel prognostic factor in resected non-small-cell lung cancerModeling cancer progression via pathway dependenciesGene expression signatures of radiation response are specific, durable and accurate in mice and humans.An expression meta-analysis of predicted microRNA targets identifies a diagnostic signature for lung cancer.The role of desmoglein-3 in the diagnosis of squamous cell carcinoma of the lung.Comparative study of gene set enrichment methods.Biobanking of human pancreas cancer tissue: impact of ex-vivo procurement times on RNA quality.Gene expression profiles of lung adenocarcinoma linked to histopathological grading and survival but not to EGF-R status: a microarray study.CXCL5 as a potential novel prognostic factor in early stage non-small cell lung cancer: results of a study of expression levels of 23 genes.A gene expression signature of RAS pathway dependence predicts response to PI3K and RAS pathway inhibitors and expands the population of RAS pathway activated tumors.Module-based prediction approach for robust inter-study predictions in microarray data.Prognostic factors in resected lung carcinomas.MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.Prognostic value of aspartyl (asparaginyl)-beta-hydroxylase/humbug expression in non-small cell lung carcinomaGene expression-based prognostic signatures in lung cancer: ready for clinical use?CFL1 expression levels as a prognostic and drug resistance marker in nonsmall cell lung cancerRandomized clinical trials with biomarkers: design issues.
P2860
Q21092374-92CFB2D2-2BAF-46C3-A917-3C0DF357D216Q22241904-A606D988-8766-46FF-8349-1CD5C9E0EBD2Q23918759-81AE932F-7031-4093-8018-758C874C6361Q23924046-711E2289-D443-4C20-ADD3-4972BF5AB5B6Q24651467-75AC1656-2239-4050-BB29-498D157AC668Q24680988-A6EC20C3-EFA2-4BB7-BE82-765692A91150Q28303718-B3858D3E-8B21-42C2-9C26-FF2B4C658469Q28384571-3351E234-C518-47B7-A767-62D0F4977775Q28385148-5E7A677D-1682-4858-95B5-9A9CEA0BE919Q28386520-C6FDC62E-BA38-48B2-A78C-808626E57CE7Q28388627-351B7289-FD28-47EE-9D75-0F39E5247B08Q28391395-C7804369-1D5E-4823-90E2-934BD0BE90DAQ28395058-50D40395-44BD-450D-A4B2-CD0576C1C48EQ28476072-9891C3D8-0CEF-4E0B-8287-A3E9C1A468C0Q28744237-2FBE651B-D5B1-4418-98F2-8BC5F654DF45Q30371443-098C303C-BCE8-45F8-80DC-42049C79C677Q30430515-98B26244-1D4E-400B-9F68-7D9EB8779BBCQ30440132-86BEDBC2-0D9E-4342-B199-297AA843861BQ30479696-5E875E15-BD68-495F-8C96-1479931023EEQ30482715-FD877D27-5A83-45DE-91CB-D6C6939773D7Q30485836-693A8EC8-569A-4DEB-A896-5195103EC7D2Q30497419-624D7B7C-2890-4061-B6AB-4C18B223109FQ30500051-AB49AFBF-3C6A-4D02-ABA2-397C8D1B9575Q33305206-EFD50343-4BB7-409E-BC98-9127ADDFEDDCQ33320177-DD1F70FC-3E04-49E5-8C24-8F8E3DC22123Q33326641-661D5BE8-D332-47F3-8719-DA814E946809Q33393471-C65B0A18-165D-41CE-B630-55ECAB50CC20Q33426224-7CB97493-5E3C-4D16-AB77-CB562D68C2F1Q33499521-A2858D00-A753-4F37-AAB8-E0B2A1B42FC2Q33531856-78533603-FCA1-4336-9246-F85ED970A89BQ33536148-84C4A730-CB11-45B1-9199-2A1B3CBDBB55Q33562564-C90D41CE-B3BE-49A1-9A29-A33C7AF24B64Q33621880-850FF00B-AAC7-40B6-8C15-518EA704A4ADQ33663130-84DAB8A8-E34A-46ED-B536-46993A529A41Q33697964-BF6E8CCD-F929-4EDE-989D-0B8C20CF398FQ33814564-E91DA5DC-25EF-4FCC-9940-2E7CAF5E1452Q33944587-736D1282-4E4B-47BF-A87E-2EA7B2B7107DQ33988433-CC6C7F6A-BE03-4F2B-BDE1-59C6E8CC6C75Q34023291-60BFD3C1-F0FC-47BA-82F6-ADAFD4EBA563Q34024227-ECC973DD-AA9B-4245-89B4-DC5AF511D7D9
P2860
A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer.
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer.
@ast
A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer.
@en
A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer.
@nl
type
label
A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer.
@ast
A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer.
@en
A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer.
@nl
prefLabel
A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer.
@ast
A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer.
@en
A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer.
@nl
P2093
P356
P1476
A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer
@en
P2093
Andrea Bild
Anil Potti
David H Harpole
Geoffrey S Ginsburg
Holly K Dressman
Jason Koontz
Joseph R Nevins
Mark A Watson
Rebecca Petersen
P304
P356
10.1056/NEJMOA060467
P407
P577
2006-08-01T00:00:00Z